Abstract
The Fourth Annual PepTalk meeting organized by the Cambridge Healthtech Institute on proteomics was held in San Diego, California from January 10 to 13, 2005. The entire meeting had an interesting name: Proteomics in a Six- Pack, and consisted of six individual meetings that ran for two days each, in two groups of concurrent sessions: (1) Fourth Annual Protein Arrays: Complex Challenges - Creative Solutions (January 10-11); (2) Eighth Annual Protein Expression (January 10-11); (3) Inaugural Protein Folding Disorders (January 10-11); (4) Second Annual Protein Process Development: Optimizing Protein Expression Through Scale-Up (January 12-13); (5) Fifth Annual The Human Proteome: Plasma Proteomics (January 12-13); and (6) Inaugural Protein Therapeutics: Minimizing Problems - Maximizing Production, Progress, and Potential (January 12-13). This was indeed what the organizers called the “protein information week”. This report summarizes The Human Proteome meeting, which ended with a joint closing plenary session with the Protein Process Development and the Protein Therapeutics meetings.
Keywords: proteomics, human proteome, plasma proteomics
Current Proteomics
Title: Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Volume: 2 Issue: 1
Author(s): Sean R. Gallagher
Affiliation:
Keywords: proteomics, human proteome, plasma proteomics
Abstract: The Fourth Annual PepTalk meeting organized by the Cambridge Healthtech Institute on proteomics was held in San Diego, California from January 10 to 13, 2005. The entire meeting had an interesting name: Proteomics in a Six- Pack, and consisted of six individual meetings that ran for two days each, in two groups of concurrent sessions: (1) Fourth Annual Protein Arrays: Complex Challenges - Creative Solutions (January 10-11); (2) Eighth Annual Protein Expression (January 10-11); (3) Inaugural Protein Folding Disorders (January 10-11); (4) Second Annual Protein Process Development: Optimizing Protein Expression Through Scale-Up (January 12-13); (5) Fifth Annual The Human Proteome: Plasma Proteomics (January 12-13); and (6) Inaugural Protein Therapeutics: Minimizing Problems - Maximizing Production, Progress, and Potential (January 12-13). This was indeed what the organizers called the “protein information week”. This report summarizes The Human Proteome meeting, which ended with a joint closing plenary session with the Protein Process Development and the Protein Therapeutics meetings.
Export Options
About this article
Cite this article as:
Gallagher R. Sean, Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome, Current Proteomics 2005; 2 (1) . https://dx.doi.org/10.2174/1570164053507817
DOI https://dx.doi.org/10.2174/1570164053507817 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design Cinnamaldehyde for the Treatment of Microbial Infections: Evidence Obtained from Experimental Models
Current Medicinal Chemistry Antiproliferative and Antifungal Activities of 1,3-diarylpropane-1,3-diones Commonly used as Sunscreen Agents
Letters in Drug Design & Discovery Using a Hybrid Radioenhancer to Discover Tumor Cell-targeted Treatment for Osteosarcoma: An In Vitro Study
Current Medicinal Chemistry p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents
Current Cancer Drug Targets Exosome-like Nanoparticles: A New Type of Nanocarrier
Current Medicinal Chemistry Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting
Current Pharmaceutical Design Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology The Emerging Role of LncRNA FENDRR in Multiple Cancers: A Review
Current Molecular Medicine Cytotoxic Impact of N-Oleoylethanolamine on Bone Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications
Current Medicinal Chemistry Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
Current Pharmaceutical Biotechnology Synthesis and Anticancer Study of Novel 4H-Chromen Derivatives
Anti-Cancer Agents in Medicinal Chemistry miRNAs Highlights in Stem and Cancer Cells
Mini-Reviews in Medicinal Chemistry Application of Microdialysis in Clinical Pharmacology
Current Clinical Pharmacology Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration
Current Cancer Drug Targets Role of ncRNAs in Development, Diagnosis and Treatment of Human Cancer
Recent Patents on Anti-Cancer Drug Discovery Chlorophylls and their Derivatives Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Peptides Homing to Tumor Vasculature: Imaging and Therapeutics for Cancer
Recent Patents on Anti-Cancer Drug Discovery